Follicular T-Cell Lymphoma
4 clinical trials · Condition
◉ Watch Follicular T-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma (NCT06561048) | Corvus Pharmaceuticals, Inc. | 2024-10-02 |
| Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma (NCT04234048) | SciTech Development, Inc. | 2023-12-18 |
| A Registry for People With T-cell Lymphoma (NCT05978141) | Memorial Sloan Kettering Cancer Center | 2023-07-27 |
| Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma (NCT04803201) | Alliance for Clinical Trials in Oncology | 2021-10-08 |
Track Follicular T-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.